MCS-2

· Health Ever Bio-Tech Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for MCS-2, covering 2015-03-03 to 2018-08-02. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of MCS-2 in the Treatment of Lower Urinary Tract Symptoms [Phase 3]